PDCD1 and sarcoma: They found that transplanted tumors are enriched for activated CD8+ T cells and PD-L1+ macrophages and concluded that PD-1 blockade and radiotherapy may be good treatments for patients with a sarcoma immune phenotype similar to those transplanted tumors [194].